If you’re a cancer patient struggling to keep up with life insurance premiums, you are not alone, and you have more options than you may realize. The single most expensive mistake we see in this industry is also one of the most common: people stop paying premiums, let their policy lapse, and walk away with nothing — never realizing the policy might have been worth tens or even hundreds of thousands of dollars to them in cash.
This post is about how to avoid that mistake.
What “Lapsing” Actually Costs You
When a life insurance policy lapses, three things happen at once:
The policy ends. The death benefit your family was counting on disappears. And every dollar of premium you’ve paid over the years — sometimes decades — stays with the insurance company.
For a term policy with no cash value, you walk away with zero. For a permanent policy, you may have access to a small cash surrender value, but that figure is typically a fraction of what the policy is actually worth on the open market.
Industry estimates suggest that millions of dollars in policy value are walked away from every year by Americans who simply didn’t know there was an alternative. For cancer patients in particular, the gap between what gets walked away from and what the policy could have fetched in a sale is often enormous.
Why Cancer Patients Often Have More Options Than Healthy Policyholders
This is the counterintuitive part, and it’s worth understanding clearly because it shapes everything that follows.
A life insurance policy on the secondary market is essentially priced by one big variable: how long the buyer expects to pay premiums before collecting the death benefit. Shorter expected timelines mean buyers can pay more upfront and still earn a return. Longer timelines push the offer price down.
In practical terms: a healthy 65-year-old might receive an offer of around 8 to 15 percent of face value for their policy. A 65-year-old with a serious cancer diagnosis might receive 30 to 60 percent of face value — sometimes more. For patients whose physicians have certified them as terminally ill under federal tax definitions, offers in the 50 to 80 percent range are not unusual.
On a $500,000 policy, that’s the difference between roughly $40,000 and $400,000. Same policy. Same insurance company. The medical situation drives an enormous portion of the answer.
This sounds harsh in print. But the practical reality is that this market structure can deliver life-changing financial support to cancer patients at exactly the moment they most need it — for treatment, for caregivers, for time with family, or simply for the dignity of not having a critical asset evaporate because the premiums became impossible.
What to Do Instead of Letting It Lapse
Before you stop paying premiums on any policy, work through these options in order:
Check for an accelerated death benefit (ADB) rider. Many policies include a built-in provision that lets you receive a portion of the death benefit early if you qualify under the policy’s definition of terminal illness. The benefit is paid by the insurance company itself, often relatively quickly, and is typically income-tax-free under Section 101(g) of the tax code. Call your insurance company directly and ask: “Do I have an accelerated death benefit or terminal illness rider, and what are its terms?”
Investigate a life settlement or viatical settlement. This is the sale of your policy to a third-party buyer for a lump sum. The buyer takes over premium payments going forward and receives the death benefit later. You walk away with cash today and no further obligations. For cancer patients, this often produces substantially more cash than any other option, and proceeds may qualify for tax-free treatment under Section 101(g) when a physician certifies terminal or chronic illness.
Consider a policy loan. If your policy has cash value, you can borrow against it at relatively favorable rates without ending the policy. This is most useful if your need is short-term and you want to preserve the death benefit for your family.
Surrender the policy. Cancel it and receive whatever cash surrender value the insurance company offers. This is rarely the best answer — but it’s still better than letting the policy lapse and getting nothing.
The point isn’t that one of these is universally right. The point is that letting the policy lapse without first finding out which of these applies to your situation is almost always the wrong move.
Term Policies Aren’t Automatically Worthless
A common misconception worth flagging directly: many cancer patients with term life policies assume they have no options because term policies have no cash value. That assumption is frequently wrong.
If your term policy includes a conversion option that allows you to convert to permanent coverage, the conversion right itself may make the policy sellable — sometimes years after issue, sometimes even after a serious diagnosis. A policy you thought had no value when you stopped being able to afford it could in fact be worth a meaningful amount today.
Even non-convertible term policies can sometimes be structured into a sale when life expectancy is short and the math works for a buyer. The window is narrower, but it’s not always zero.
If you have a term policy and you’re about to let it lapse, please get it reviewed before that happens. The review costs you nothing.
Group Coverage Through an Employer
If you currently have group life insurance through an employer and you’re considering reducing hours, taking medical leave, or stopping work entirely, there’s a time-sensitive piece worth knowing.
Many group policies allow conversion to an individual policy within a defined window after coverage ends — often 30 days, sometimes longer. A converted individual policy may have settlement value. Lapsed group coverage typically does not.
This means the difference between “I let my group coverage end when I stopped working” and “I converted my group coverage to an individual policy first, then explored my options” can be the difference between zero and a six-figure outcome. If you’re in this situation, find out what your conversion rights are now, before any window closes.
A Brief Word on Time Pressure
We want to be careful here, because pressure tactics are one of the warning signs of a less reputable operator. But there is sometimes a real reason to act sooner rather than later, and it’s worth saying out loud.
A policy review and evaluation takes time — typically two to six weeks for medical records to be gathered, another one to three weeks for underwriting, then the offer itself. If your medical situation is changing, the picture an underwriter sees today reflects today’s reality, not yesterday’s or next month’s. And if premiums are due in a few weeks and you don’t have a plan, the window for converting that policy into useful cash narrows quickly.
None of this means you should rush a decision. It means you shouldn’t postpone the exploration. Finding out what your options are costs nothing and creates no obligation to act.
The Bottom Line
If you are a cancer patient — or a family member of one — and a life insurance policy is at risk of lapsing because the premiums have become unmanageable, please stop and find out what the policy might be worth first. Even a partial settlement is dramatically better than zero, and for cancer patients the numbers are often substantial.
Every year, families that could have received meaningful financial support during treatment instead receive nothing because no one told them their policy had market value. You don’t have to be one of them.
To find out what your policy might be worth
A no-cost, no-obligation policy review is available through Settlement Group, a licensed life settlement provider. Call 912-882-0840, email inquiries@settlementgroup.io, or visit settlementgroup.io.